Biotech company Amyris launches FDA-regulated, sugarcane-derived squalane

By Deanna Utroske contact

- Last updated on GMT

Biotech company Amyris launches FDA-regulated, sugarcane-derived squalane

Related tags: Biotech company amyris, Biotechnology

The cosmetics, personal care, and fragrance ingredient maker has just announced the availability of a pharmaceutical grade of its bio-based squalane. Having a USP certified ingredient not only opens up the pharma market for Amyris but also bolsters the company’s reputation in the sustainable ingredient space overall.

A joint venture between Amyris and NIKKOL made this ingredient launch possible. The two companies formally joined forces as Aprinnova late last year, as Cosmetics Design reported​.

“NIKKOL has been involved in the sugarcane-based squalane business since the product’s inception by Amyris and we believe this is an opportune time to join forces,” ​remarked Shizuo Ukaji, president and CEO of Nikko Chemical (the central company of the NIKKOL Group), adding that, “By working together, we believe the additional financial, marketing, innovation, and business development synergies will lead to a significant expansion in market applications.”

Case in point

This new launch is clearly one such application.

“We are very pleased to have met the USP and NF requirements, which showcases our adherence to a philosophy of manufacturing and distributing the highest performance, sustainable products through a best-in-class production process,”​ acknowledges Caroline Hadfield, senior vice president of personal care at Amyris, in a media release.

Hadfield goes on to say that, “We are delighted to provide a sustainable and naturally-sourced squalane to this important new market for Aprinnova while providing our customers and their end market customers with non-animal, cruelty-free high-performance ingredients for a growing variety of products.”

Industry shift

As biotech is increasingly common, formulators and regulators are compensating for the new ingredients.

“Neossance Squalane USP is derived from biotechnology via the fermentation of sugar cane and meets the newly modified definition in Squalane Monograph USP41-NF36, which now includes ‘Squalane, derived from ß-farnesene, a fermentation product of plant-sugars’. The Standard USP36 General Notices and Requirements establishes a February 1st, 2018 implementation date for marketing,” ​as marketing materials for the ingredient explain.

---

DeannaUtroskeEditor

Deanna Utroske, CosmeticsDesign.com Editor, covers beauty business news in the Americas region and publishes the weekly Indie Beauty Profile column, showcasing the inspiring work of entrepreneurs and innovative brands.

Related topics: Formulation & Science, Skin Care

Related news

Show more

Related products

show more

Your face mask might not be as attractive as you think!

Your face mask might not be as attractive as you think!

Vantage Specialty Ingredients, Inc. | 12-Apr-2019 | Product Brochure

There seems to be no skin condition that a good face mask can’t cure. This explains why the category has been so successful over the past few years and...

SYNETH™ Polyglyceryl Esters

SYNETH™ Polyglyceryl Esters

Lonza | 01-Apr-2019 | Product Brochure

Everything a Collection of Specialty Esters can do for a Breakthrough Product Transformation

AlphaVelvety awakens senses of nature in cosmetics

AlphaVelvety awakens senses of nature in cosmetics

Citróleo Group | 18-Mar-2019 | Application Note

The AlphaVelvety has been developed for an original and exclusive ratio of oleic, myristic, lauric, palmitic and stearic fatty acids, ensuring to the formulator...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars